1-N'-(2-methylpropyl)ethane-1,1-diamine

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 1-N'-(2-methylpropyl)ethane-1,1-diamine
• 化学式: C₆H₁₆N₂
• 分子量: 116.2
• InChiKey: LZKSTLZTBQJTKJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  38
• 氢给体数：
  2
• 氢受体数：
  2

文献信息

• Modification of colloidal nanocrystals
  申请人：University of Utah Research Foundation

  公开号：US10290387B2

  公开（公告）日：2019-05-14

  Methods for precise and predictable modification of previously synthesized nanocrystals. The methods rely on the solubility behavior of crystalline materials to provide for controlled reversal of the nanocrystal growth process (i.e., dissolution). A method for post-synthesis modification of colloidal nanocrystals includes (1) providing a first nanocrystal having a first size and a first shape, (2) forming a reaction mixture that includes the nanocrystal, at least one ligand capable of binding to at least one component of the nanocrystal, at least one solvent, and an inert gas atmosphere, and (3) modifying the size and/or shape of the nanocrystal in the reaction mixture for a period of time at a temperature in a range from about 100° C. to about 240° C. so as to produce at least a second nanocrystal having a second size and/or a second shape.

  对先前合成的纳米晶体进行精确和可预测改性的方法。这些方法依赖于晶体材料的溶解行为，以实现纳米晶体生长过程的可控逆转（即溶解）。合成后修饰胶体纳米晶体的方法包括：(1) 提供具有第一尺寸和第一形状的第一纳米晶体；(2) 形成反应混合物，其中包括纳米晶体、至少一种能够与纳米晶体的至少一种成分结合的配体、至少一种溶剂和惰性气体环境；(3) 在约 100°C 至约 240°C 的温度范围内，在一段时间内修饰反应混合物中纳米晶体的尺寸和/或形状。至约 240 摄氏度范围内的温度下改变反应混合物中纳米晶体的尺寸和/或形状一段时间，以产生至少具有第二尺寸和/或第二形状的第二纳米晶体。
• SPIRO COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS
  申请人：Zhang Jiancun

  公开号：US20140147412A1

  公开（公告）日：2014-05-29

  Disclosed are spiro compounds of formula (I), or stereomers, geometric isomers, tautomers, nitrogen oxides, hydrates, solvates, metabolites, pharmaceutically acceptable salts or prodrugs thereof. The compounds can be used to treat hepatitis C virus (HCV) infection or hepatitis C disease. Furthermore disclosed are pharmaceutical compositions containing the compounds and the method of using the compounds or pharmaceutical compositions in the treatment of HCV infection or hepatitis C disease.
• CHEMICAL PROCESSES AND COMPOSITIONS FOR MECHANICALLY STABILIZING CELLULOSE-LIGNIN BASED ARTIFACTS
  申请人：Lawrence Livermore National Security, LLC

  公开号：US20200332026A1

  公开（公告）日：2020-10-22

  In one inventive concept, a product for modifying a cellulose-lignin material with siloxane includes a mixture having a siloxane species, a metal catalyst, and a nonpolar solvent. The mixture is operative to modify a cellulose-lignin material with siloxane upon wetting of the cellulose-lignin material with the mixture and subsequent drying of the cellulose-lignin material. In another inventive concept, a product includes a siloxane-modified cellulose-lignin material having a cellulose-lignin network and a network of siloxane in cross-linking bridges in the cellulose-lignin network.
• US9416139B2
  申请人：——

  公开号：US9416139B2

  公开（公告）日：2016-08-16